S1PR2 inhibition mitigates cognitive deficit in diabetic mice by modulating microglial activation via Akt-p53-TIGAR pathwayINTERNATIONAL IMMUNOPHARMACOLOGYIF4.72024-01-013PRE
Necrostatin-1 S mitigates type-2 diabetes-associated cognitive decrement and lipotoxicity-induced neuro-microglia changes through p-RIPK-RIPK3-p-MLKL axis (vol 38, pg 1, 2023)METABOLIC BRAIN DISEASEIF3.52023-05-190OA
Necrostatin-1S mitigates type-2 diabetes-associated cognitive decrement and lipotoxicity-induced neuro-microglia changes through p-RIPK-RIPK3-p-MLKL axisMETABOLIC BRAIN DISEASEIF3.52023-03-1010PRE
Development of trisubstituted thiophene-3-arboxamide selenide derivatives as novel EGFR kinase inhibitors with cytotoxic activityRSC MEDICINAL CHEMISTRYIF3.62023-01-012PRE
NLRP3 inflammasomes: A potential target to improve mitochondrial biogenesis in Parkinson's diseaseEUROPEAN JOURNAL OF PHARMACOLOGYIF4.72022-11-0128PRE
Neuroepigenetic Changes in DNA Methylation Affecting Diabetes-Induced Cognitive ImpairmentDNA甲基化的神经表观遗传学变化影响糖尿病引起的认知障碍CELLULAR AND MOLECULAR NEUROBIOLOGYIF4.82022-09-227PRE
Metabolic Regulation of Glia and Their Neuroinflammatory Role in Alzheimer's DiseaseCELLULAR AND MOLECULAR NEUROBIOLOGYIF4.82021-09-1333PRE
Anxiety: An ignored aspect of Parkinson's disease lacking attentionBIOMEDICINE & PHARMACOTHERAPYIF7.52020-11-0143OAAI